Liver Injury in Children with COVID-19: A Systematic Review
DOI:
https://doi.org/10.58427/apghn.2.1.2023.1-15Keywords:
acute liver injury, children, COVID-19, prognosisAbstract
Background: The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with high morbidity and mortality rates. COVID-19 in children showed different unique presentations. Besides respiratory symptoms, a growing body of evidence indicates multi-organ manifestation, including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while on the other hand, there is compelling but currently limited evidence in children. In this systematic review, we summarize data of updated literature regarding the evidence of acute liver injury in children with COVID-19.
Methods: Online scientific articles were explored on PubMed and Google Scholar databases using keywords. The systematic review was performed under the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines
Results: The literature search yielded 238 articles, of which 16 were identified as relevant to the topic and met the inclusion criteria. A total of 564 pediatric patients were confirmed positive for COVID-19 by PCR examination, involving 298 (52.9%) boys and 266 (47.1%) girls with an age range of 1 day - 17 years. Liver injuries have been reported in pediatric COVID-19 patients, with prevalence ranging from 1.5 to 52%.
Conclusion: SARS-CoV-2 virus infection in children shows a unique presentation. Several reports suggest that liver injury correlates with the severity of COVID-19 disease. Therefore, monitoring liver function in COVID-19 patients is important to assess the prognosis.
References
Guimarães D, Pissarra R, Reis‐Melo A, Guimarães H. Multisystem Inflammatory Syndrome in Children (MISC): a systematic review. International Journal of Clinical Practice 2021;27:e14450. https://doi.org/10.1111/ijcp.14450
Li R, Qiao S, Zhang G. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV. J Infect. 2020;80(4): 469–96. https://doi.org/10.1016/j.jinf.2020.02.013
Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: the hepatic aspect of the respiratory syndrome—what we know so far. World Journal of Hepatology. 2020;12(12):1182. https://doi.org/10.4254/wjh.v12.i12.1182
Perez A, Cantor A, Rudolph B, Miller J, Kogan‐Liberman D, Gao Q, et al. Liver involvement in children with SARS‐COV‐2 infection: Two distinct clinical phenotypes caused by the same virus. Liver International. 2021;41(9):2068-75. https://doi.org/10.1111/liv.14887
Perez A, Kogan-Liberman D, Sheflin-Findling S, Raizner A, Ahuja KL, Ovchinsky N. Presentation of severe acute respiratory syndrome-coronavirus 2 infection as cholestatic jaundice in two healthy adolescents. The Journal of Pediatrics. 2020;226:278-80. https://doi.org/10.1016/j.jpeds.2020.07.054
Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, et al. A 55-day-old female infant infected with 2019 novel coronavirus disease: presenting with pneumonia, liver injury, and heart damage. The Journal of infectious diseases. 2020;221(11):1775-81. https://doi.org/10.1093/infdis/jiaa113
Saeed A, Shorafa E, Shahramian I, Afshari M, Salahifard M, Parooie F. An 11-year-old boy infected with COVID-19 with presentation of acute liver failure. Hepatitis Monthly. 2020;20(6):1-8. https://doi.org/10.5812/hepatmon.104415
Parcha V, Booker KS, Kalra R, Kuranz S, Berra L, Arora G, et al. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Scientific reports. 2021;11(1):1-10. https://doi.org/10.1038/s41598-021-89553-1
Liu M, Tannuri U, de Carvalho WB, Bastos KL, Rodriguez IS, Johnston C, et al. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients. Clinics. 2020;75:e2250. https://doi.org/10.6061/clinics/2020/e2250
Liu X, Tang J, Xie R, Li W, Chen J, Guo Y, et al. Clinical and epidemiological features of 46 children< 1 year old with coronavirus disease 2019 in Wuhan, China: a descriptive study. The Journal of infectious diseases. 2020;222(8):1293-7. https://doi.org/10.1093/infdis/jiaa472
Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults. Pediatric pulmonology. 2020;55(5):1169-74. https://doi.org/10.1002/ppul.24718
Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World Journal of Pediatrics. 2020;16:251–259. https://doi.org/10.1007/s12519-020-00354-4
Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet infectious diseases. 2020;20(6):689-96. https://doi.org/10.1016/S1473-3099(20)30198-5
Wang Y, Liu S, Liu H, Wei L, Fang L, Jiang L et al. SARS-CoV- 2infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807-816. https://doi.org/10.1016/j.jhep.2020.05.002
Sgouropoulou V, Vargiami E, Kyriazi M, Papadimitriou E, Agakidis C, Zafeiriou D. Transient Severe Liver Injury: A Unique Presentation of COVID-19 Disease in a Pediatric Patient. The Pediatric Infectious Disease Journal. 2021;40(5):e204-5. https://doi.org/10.1097/INF.0000000000003104
Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis. 2020;71:1547-1551. https://doi.org/10.1093/cid/ciaa198
Sica R, Pennoni S, Penta L, Di Cara G, Verrotti A. New onset of hepatic steatosis post-severe multisystem inflammatory syndrome in children (MIS-C): A case report. International Journal of Environmental Research and Public Health. 2021;18(13):6961. https://doi.org/10.3390/ijerph18136961
Memar EH, Mamishi S, Ekbatani MS, Alimadadi H, Yaghmaei B, Chegini V, et al. Fulminant hepatic failure: a rare and devastating manifestation of Coronavirus disease 2019 in an 11-year-old boy. Archives De Pediatrie. 2020;27(8):502-5. https://doi.org/10.1016/j.arcped.2020.09.009
Zhu C, Pocino K, Stefanile A, Marino M, Miele L, Gulli F, et al. COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel. Scandinavian Journal of Immunology. 2021;93(3):e12977. https://doi.org/10.1111/sji.12977
Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, et al. Liver injury in COVID-19: clinical features and treatment management. Virology Journal. 2021;18(1):1-9. https://doi.org/10.1186/s12985-021-01593-1
Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, et al. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomedicine & Pharmacotherapy. 2020;28:1058-1064. https://doi.org/10.1016/j.biopha.2020.111064
de Sousa Moreira JL, de Sousa Barbosa SM, Júnior JG. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: an integrative review. Clinics and Research in Hepatology and Gastroenterology.2021;23:1017-22. https://doi.org/10.1016/j.clinre.2021.101752
Gadour E, Shrwani K, Hassan Z. Covid-19 induced hepatitis (CIH), definition and diagnostic criteria of a poorly understood new clinical syndrome. World J Gastroenterol, Hepatol and Endoscop. 2020;1(2):1-6. https://doi.org/10.47690/WJGHE.2020.3301
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2021(5):1-9. https://doi.org/10.1101/2020.02.03.931766
Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Van Poucke S, Liu WY, Zheng MH. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. Journal of clinical and translational hepatology. 2020;8(1):18. https://doi.org/10.14218/JCTH.2020.00018
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and Immunological features of Severe and Moderate Coronavirus Disease 2019. J Clin Invest. 2020;130(5):2620:9. https://doi.org/10.1172/JCI137244
Li Y, Xiao S-Y. Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications. J Med Virol. 2020;92(9):1491-94. https://doi.org/10.1002/jmv.25973
Yang RX, Zheng RD, Fan JG. Etiology and management of liver injury in patients with COVID-19. World Journal of Gastroenterology 2020;26(32):4753. https://doi.org/10.3748/wjg.v26.i32.4753
Napodano C, Pocino K, Stefanile A, Marino M, Miele L, Gulli F, Basile V, et al. COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel. Scandinavian Journal of Immunology. 2021;93(3):e12977. https://doi.org/10.1111/sji.12977
Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?. Archives of toxicology. 2020;94(4):1367-9. https://doi.org/10.1007/s00204-020-02734-1
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327-36. https://doi.org/10.1056/NEJMoa2007016
Wang D, Ju XL, Xie F, Lu Y, Li FY. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Zhonghua Er Ke Za Zhi. 2020; 58: 269-74. https://doi.org/10.3760/cma.j.cn112140-20200225-00138
Tan YP, Tan BY, Pan J, Wu J, Zeng SZ, Wei HY. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China. J Clin Virol. 2020;127:104353. https://doi.org/10.1016/j.jcv.2020.104353
Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2020;5(7):667-78. https://doi.org/10.1016/S2468-1253(20)30126-6
Medetalibeyoglu A, Catma Y, Senkal N, Ormeci A, Cavus B, Kose M, et al. The effect of liver test abnormalities on the prognosis of COVID-19. Annals of Hepatology. 2020;19(6):614-21. https://doi.org/10.1016/j.aohep.2020.08.068
Zinellu A, Arru F, De Vito A, Sassu A, Valdes G, Scano V, et al. The De Ritis ratio as prognostic biomarker of in‐hospital mortality in COVID‐19 patients. European journal of clinical investigation. 2021;51(1):e13427. https://doi.org/10.1111/eci.13427
Published
Issue
Section
License
Copyright (c) 2023 Satrio Wibowo, Tita Luthfia Sari, Muhammad Irawan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
